Cellular Senescence in Neurodegenerative Disorders Including MS
A review highlights that cellular senescence is linked to neurodegenerative disorders, such as multiple sclerosis. The study focuses on how senescence affects various cell types in the nervous system.
- Tags
- #MSResearch
- Most relevant to
- —
- Human efficacy
- Not established from this source
- Mechanism
- Not reported
- Evidence strength
- Not graded
- Outcome
- Not reported
Why it matters
Understanding the role of cellular senescence could help elucidate mechanisms underlying multiple sclerosis and other neurodegenerative diseases, potentially guiding future research in treatment approaches.
What this does not prove
The review notes significant challenges in applying senotherapeutic strategies clinically, especially in targeting specific cell types and the lack of suitable biomarkers for assessment.
Next milestone
No next milestone was established from the available source.
Study facts
- Study design
- Not reported
- Participants / samples
- Not reported
- Randomised
- Not reported
- Controlled
- Not reported
- Primary endpoint met
- Not reported
- Relevant MS type
- Not reported
- Publication date
- 2026-10-23
- Evidence reviewed
- Abstract only
- Regulatory approval
- Not reported
- Research areas
- Not classified
- Biological target
- Not reported
- Pathway
- Not reported
- Population
- Not reported
- Size of effect
- Not reported
- Secondary endpoints
- Not reported
- MRI endpoints
- Not reported
- Biomarkers
- Not reported
- Safety
- Not reported
Original sources
- Primary evidenceCellular senescence in ageing and neurodegenerative disorders: Molecular mechanisms, biomarkers, and therapeutic strategies. ↗DOI: 10.1016/j.pnpbp.2026.111985
Supporting passages (4)
findingsThe present study aims to explore the increasing relevance of cellular senescence among key cell types, including neurons, astrocytes, neural progenitor cells, microglia and oligodendrocyte-lineage cells across neurodegenerative ailments such as Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis and multiple sclerosis.
limitationsIt also points out the challenges in translating these approaches to clinical application, such as targeting specific cell types and the lack of suitable biomarkers.
publication datePublication date: 2026-10-23
peer reviewedPublication types: Journal Article; Review
AI assessment, not yet reviewed by a person · version 1 · Community votes are separate from evidence review.